|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/14 | |
| A61K 31/4545 | |||
| A61K 47/32 | |||
| A61K 47/38 | |||
| A61K 31/427 | |||
| A61P 31/14 |
| (11) | Number of the document | 3285768 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16783855.6 |
| Date of filing the European patent application | 2016-04-21 | |
| (97) | Date of publication of the European application | 2018-02-28 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/028651 |
| Date | 2016-04-21 |
| (87) | Number | WO 2016/172342 |
| Date | 2016-10-27 |
| (30) | Number | Date | Country code |
| 201562150721 P | 2015-04-21 | US | |
| 201562153815 P | 2015-04-28 | US |
| (72) |
GOSSELIN, Patrick, US
BETANCOURT, Aimesther, US
|
| (73) |
Eiger Biopharmaceuticals, Inc.,
2155 Park Boulevard, Palo Alto, CA 94306,
US
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING LONAFARNIB AND RITONAVIR |
| PHARMACEUTICAL COMPOSITIONS COMPRISING LONAFARNIB AND RITONAVIR |